| abstract |
The present invention relates to chemotherapeutic drug combinations containing heterobinuclear Cu (II) -Mn (II) complexes. The object of the present invention is to actively use in chemotherapy, have anticancer properties, have no side effects, promote cell penetration, show selectivity only to cancer cells, and maintain healthy cells. It is to provide a drug combination that does not hurt, is not toxic to the tissues and organs in the body, is easily prepared, and provides a decisive and rapid treatment. |